Michael Halstead
Chief Executive Officer at Cybin Inc. (HELP) since September 2026
Michael Halstead has filed 32 insider reports with the SEC since February 2021, as chief Executive Officer at Cybin Inc. (HELP) and president at Intra-Cellular Therapies, Inc. (ITCI). In the last 12 months Michael Halstead bought $1.35M of stock on the open market. In the latest amended filing, on September 21, 2026, Michael Halstead bought 100,000 shares of Cybin Inc. (HELP) for $1.35M at an average of $13.47.
- Filings
- 32
- Companies
- 2
- Bought on market
- $1.35M
- Sold on market
- $24.6M
Companies where Michael Halstead is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officersince September 2026 | 168,568 | $1.35M | $13.47 | $7.67-43% | Sep 21, 2026 | ||
| President | 0 | $24.6M | Apr 2, 2025 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Sep 21, 2026+$1.35MHELPChief Executive Officer Halstead Michael bought $1,347,050 worth of shares (100,000 units at $13.47), increasing direct ownership by 146% to 168,568 unitsForm 4/AOpen-market purchase
- Sep 17, 2026HELPNew insider Halstead Michael claimed ownership of 68,568 sharesForm 3New insider
- Apr 2, 2025ITCIPresident Halstead Michael returned $2,812,524 worth of shares to the company (21,307 units at $132.00), closing all direct ownership in the companyForm 4Grant or awardSale back to the company
- Mar 10, 2025ITCIPresident Halstead Michael converted options into 20,478 shares and covered exercise/tax liability with 10,475 shares, increasing direct ownership by 88% to 21,307 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 1, 2025ITCIPresident Halstead Michael covered exercise/tax liability with 6,261 shares and converted options into 12,239 shares, increasing direct ownership by 112% to 11,304 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 3, 2025ITCIPresident Halstead Michael was granted 11,017 shares and covered exercise/tax liability with 5,691 sharesForm 4Grant or awardShares withheld for taxes or exercise price
- Nov 13, 2024-$3.69MITCIPresident Halstead Michael sold $3,692,100 worth of shares (41,583 units at $88.79) and exercised 41,583 shares at a strike of $29.77Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 12, 2024~$3.7MITCIMichael Halstead plans to sell 41,583 shares (~$3.7M)Form 144Planned sale10b5-1 plan
- Mar 11, 2024-$1.35MITCIHalstead Michael sold $1,353,235 worth of shares (20,477 units at $66.09) and converted options into 7,345 shares, closing all direct ownership in the companyForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 11, 2024~$485KITCIMichael Halstead plans to sell 7,345 shares (~$485K)Form 144Planned sale10b5-1 plan
- Mar 6, 2024ITCIHalstead Michael converted options into 13,132 sharesForm 4Exercise or conversion of a derivative
- Mar 7, 2024~$869KITCIMichael Halstead plans to sell 13,132 shares (~$869K)Form 144Planned sale10b5-1 plan
- Mar 1, 2024ITCISEC Form 4 filed by Halstead MichaelForm 4Grant or award
- Feb 26, 2024-$550KITCIHalstead Michael converted options into 7,907 shares and sold $549,784 worth of shares (7,907 units at $69.53)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 26, 2024~$550KITCIMichael Halstead plans to sell 7,907 shares (~$550K)Form 144Planned sale10b5-1 plan
- Feb 2, 2024-$788KITCIHalstead Michael was granted 11,860 shares and sold $787,719 worth of shares (11,860 units at $66.42)Form 4Grant or awardOpen-market sale10b5-1 plan
- Feb 2, 2024~$2.27MITCIMichael Halstead plans to sell 33,885 shares (~$2.27M)Form 144Planned sale10b5-1 plan
- Jan 11, 2024-$3.34MITCIHalstead Michael exercised 50,000 shares at a strike of $13.60 and sold $3,341,699 worth of shares (50,000 units at $66.83)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 11, 2024~$3.34MITCIMichael Halstead plans to sell 50,000 shares (~$3.34M)Form 144Planned sale10b5-1 plan
- Nov 13, 2023~$2.69MITCIMichael Halstead plans to sell 50,000 shares (~$2.69M)Form 144Planned sale10b5-1 plan
- Jan 4, 2016ITCISEC Form 4 filed by Halstead Michael (Amendment)Form 4Grant or award
- Mar 13, 2023-$1.05MITCISEC Form 4: Halstead Michael was granted 16,708 shares, sold $1,050,092 worth of shares (24,052 units at $43.66) as part of a pre-agreed trading plan and converted options into 7,344 sharesForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 6, 2023ITCISEC Form 4 filed by Halstead MichaelForm 4Grant or award
- Feb 24, 2023-$372KITCISEC Form 4: Halstead Michael converted options into 7,906 shares and sold $371,819 worth of shares (7,906 units at $47.03) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 21, 2023-$522KITCISEC Form 4: Halstead Michael converted options into 11,139 shares and sold $521,699 worth of shares (11,139 units at $46.84) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 1, 2022-$2.69MITCISEC Form 4: Halstead Michael exercised 50,000 shares at a strike of $15.47 and sold $2,686,514 worth of shares (50,000 units at $53.73) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 10, 2022ITCISEC Form 4 filed by Halstead MichaelForm 4Grant or award
- Feb 22, 2022-$617KITCISEC Form 4: Halstead Michael converted options into 11,139 shares and sold $617,100 worth of shares (11,139 units at $55.40) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 10, 2022-$801KITCISEC Form 4: Halstead Michael converted options into 19,639 shares and sold $800,774 worth of shares (19,639 units at $40.77) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 21, 2021-$8.41MITCISEC Form 4: Halstead Michael exercised 176,863 shares at a strike of $16.38 and sold $8,412,278 worth of shares (176,863 units at $47.56) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 23, 2021ITCISEC Form 4 filed by Michael HalsteadForm 4Grant or award
- Feb 19, 2021-$437KITCISEC Form 4: Michael Halstead exercised 11,139 units of Common Stock at a strike of $0.00 and sold $437,133 worth of Common Stock (11,139 units at $39.24)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
Also sits on boards with
Officers and directors who share two or more companies with Michael Halstead.
Compare Michael Halstead with
- Michael Halstead vs Suresh K. Durgam2 shared
- Michael Halstead vs So Eric H. L.1 shared
- Michael Halstead vs Greg Cavers1 shared
- Michael Halstead vs Paul Glavine1 shared
- Michael Halstead vs Eduardo Rene Salas1 shared
- Michael Halstead vs Rory B Riggs1 shared
Other insiders at the same companies
- So Eric H. L.HELP
- Greg CaversHELP
- Paul GlavineHELP
- Eduardo Rene SalasITCI
- Rory B RiggsITCI
- Robert L Van NostrandITCI
- Mark NeumannITCI
- Joel S MarcusITCI
- Sharon MatesITCI
- Sanjeev NarulaITCI
- Alexandria Venture Investments, LLCITCI
Questions about Michael Halstead
- What is Michael Halstead's role at Cybin Inc.?
- Michael Halstead reports to the SEC as chief Executive Officer at Cybin Inc. (HELP), according to the latest filing on September 21, 2026. Michael Halstead has also filed as president at Intra-Cellular Therapies, Inc. (ITCI).
- How many shares does Michael Halstead own?
- After the latest filing that states it, Michael Halstead directly owned 168,568 shares of Cybin Inc. (HELP). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Halstead bought or sold stock recently?
- The most recent open-market purchase was on September 21, 2026: bought 100,000 shares of Cybin Inc. (HELP) for $1.35M at an average of $13.47. The most recent open-market sale was on November 13, 2024: sold 41,583 shares of Intra-Cellular Therapies, Inc. (ITCI) for $3.69M at an average of $88.79.
- How do I get alerts when Michael Halstead files?
- Follow Michael Halstead on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael Halstead filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Michael Halstead (SEC CIK 0001521548). Totals count each trade once, skipping amendments whose original is on file, from Feb 23, 2021 on. View on SEC EDGAR